Vikas Sinha, Director at Verona Pharma plc (VRNA), sold 20,000 shares at $8.92 ($178K) on 2025-04-29, disclosed to the SEC on 2025-05-01.
Scheduled sale ($178k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.92 | 4,952 | $44K | 24.8% |
| 2 | $8.92 | 15,048 | $134K | 75.2% |
| Total | $8.92 avg | 20,000 | $178K | 100% |
| Filing → |
| VRNA | SELL | 2025-08-05 | $114K | — | Filing → |
| VRNA | SELL | 2025-05-22 | $2.9M | — | Filing → |
| VRNA | SELL | 2025-05-22 | $1.5M | — | Filing → |